Acreage Holdings
A US multi-state cannabis operator tied to Canopy Growth's American expansion strategy, best known for The Botanist retail brand.
Acreage is one of the older US multi-state operators, but its real story is corporate, not consumer. Since 2019 it has been locked into a complicated option deal with Canadian giant Canopy Growth that only triggers if US federal cannabis law changes. That structure has shaped almost everything about the company — its footprint, its restructurings, its share classes. If you're researching Acreage as a shopper, you mostly know it through The Botanist dispensaries. If you're researching it as an investor or operator, read the SEC and SEDAR filings, not the press releases.
What it is
Acreage Holdings is a US cannabis operator headquartered in New York City that cultivates, processes, and sells cannabis through licensed state-regulated businesses. The company was assembled by Kevin Murphy through High Street Capital Partners and went public on the Canadian Securities Exchange in late 2018 via a reverse takeover [1][2]. At various points Acreage has reported operations or license interests across multiple US states, with a focus on the Northeast and Midwest [1]. Its best-known consumer-facing brand is The Botanist, used for dispensaries and a line of branded products [3].
Ownership and corporate structure
Acreage's ownership is unusually complicated, even by cannabis-industry standards. In 2019, Canopy Growth Corporation — a large Canadian licensed producer — announced an agreement to acquire Acreage contingent on US federal legalization of cannabis [4]. That deal has been amended multiple times. In 2020, the structure was reorganized into Fixed and Floating share classes [5]. In 2022–2023, Canopy Growth created Canopy USA, LLC as a US-domiciled holding vehicle intended to consolidate its US conditional assets — including the Acreage option, Wana, and Jetty — without Canopy Growth itself touching plant-touching US operations [6][7]. Whether and when Canopy USA will actually close on Acreage depends on regulatory, exchange, and shareholder conditions described in those filings [6]. Readers should treat the relationship as an option and contractual arrangement, not a completed acquisition, until filings confirm otherwise.
Market and category focus
Acreage operates as a vertically integrated MSO, meaning it has historically held interests across cultivation, manufacturing, wholesale, and retail in the states where it is licensed [1]. Its footprint has shifted over time through divestitures and restructurings; current state-by-state license status should be confirmed directly with state cannabis regulators rather than from secondary sources. The company has participated in both medical and adult-use programs depending on the state.
Notable brands and products
The most visible Acreage brand is The Botanist, used both for retail dispensaries and for a house line of flower, vapes, and other formats [3]. Acreage has also operated or licensed other regional brands over the years and at times distributed third-party brands in its dispensaries. We are not recommending any specific product. Cannabis product quality, potency, and formulation vary by state, batch, and manufacturing partner, and Weedpedia does not independently test Acreage products.
Reputation, controversies, and regulatory notes
Acreage has drawn attention for several reasons beyond its products:
- The Canopy deal. The original 2019 arrangement was one of the largest conditional cannabis transactions ever announced and has been repeatedly restructured as US federal reform stalled [4][5][6]. Coverage in trade and financial press has been mixed, often skeptical about timing [7].
- Board and governance. Founder Kevin Murphy stepped down as CEO in 2020 amid investor pressure during a broader cannabis-sector downturn [8]. Leadership has changed several times since.
- Financial performance. Like most US MSOs, Acreage has reported significant losses and impairments in various periods; specifics should be read from its quarterly filings rather than summarized here, because numbers change [1].
We are not aware, as of the last-checked date, of major product-safety enforcement actions against Acreage specifically. That is not a clean bill of health — it just means we did not find verifiable, citable actions to report. Check state regulator bulletins for the jurisdictions where you intend to buy.
Availability and legal-market notes
Acreage and The Botanist operate only in US state-legal markets where the company holds the relevant licenses. Cannabis remains a Schedule I controlled substance under US federal law as of the last-checked date [9]. Interstate shipment of cannabis products is illegal, regardless of what any brand's website or marketing implies. If you see Acreage or Botanist-branded products advertised for mail-order delivery across state lines, that is a red flag, not a feature.
What to verify before relying on brand claims
Before treating any Acreage-related claim as current fact, check:
- Ownership status. Has Canopy USA closed on Acreage, or is it still an option? Confirm via SEDAR+ (Canopy Growth filings) and any US SEC disclosures [6].
- State licenses. Look up the specific dispensary or facility on the state regulator's license portal. License holders sometimes differ from the marketing brand.
- Product COAs. For any specific product, ask the dispensary for the certificate of analysis (lab test) for that batch. Brand reputation is not a substitute for a current COA.
- Financial claims. Use the most recent quarterly filings, not press releases or investor decks.
- News recency. The MSO sector restructures constantly. A claim that was true 12 months ago may not be true today.
Profile last checked: 2025.
Sources
- Reported Williams, S. (2018). Acreage Holdings begins trading on the Canadian Securities Exchange. MarketWatch / industry coverage of the November 2018 RTO listing.
- Reported MJBizDaily staff. Coverage of Acreage Holdings' founding, leadership, and US multi-state expansion.
- Reported Acreage Holdings rebrands US retail footprint under The Botanist banner. Industry trade coverage.
- Reported Williams-Grut, O. (2019). Canopy Growth announces conditional US$3.4B deal to acquire Acreage Holdings upon US federal legalization. Reuters / Bloomberg coverage, April 2019.
- Reported Coverage of the 2020 amendment to the Canopy–Acreage arrangement creating Fixed and Floating share classes.
- Government Canopy Growth Corporation public filings, including disclosures regarding Canopy USA, LLC and the conditional acquisition of Acreage Holdings. Available via SEDAR+ (Canadian Securities Administrators).
- Reported Coverage of Canopy Growth's creation of Canopy USA to consolidate conditional US assets (Acreage, Wana, Jetty).
- Reported Reports on the 2020 leadership transition at Acreage Holdings, including Kevin Murphy stepping down as CEO.
- Government U.S. Drug Enforcement Administration. Controlled Substances Act scheduling; marijuana listed as Schedule I.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Canopy Growth — Canadian licensed cannabis producer with multiple consumer brands and a separate U.S.-focu...